Chair: Colleen Le Prell, PhDCo-Chair: Gayla Poling AuD, PhD
The fields of audiology and hearing science are vastly advancing. Nearly a quarter of Americans older than 12 years of age are estimated to have some degree of hearing loss. As most older adults will experience hearing loss, inner-ear regeneration and cell therapies would significantly expand remediation options beyond amplification devices alone. Research indicates that inner-ear regenerative therapies are promising and could lead to significant changes in audiological management. Multiple therapeutics are currently under evaluation in animal models and human clinical trials, with the potential for new medicines thus on the horizon.
This virtual conference aims to describe the current state of these therapies and provide future expectations for clinicians providing hearing-related services.
Agenda
| 8:00–8:15 am | Welcome–Background and Introductory Session Bopanna Ballachanda, PhD, Academy President Colleen Le Prell, PhD, ARC 2023 Program Chair |
| 8:15–9:00 am | Developing and Testing Therapies for the Inner Ear Lakeisha Henry, MD, US Air Force (RET) |
| 9:00–9:45 am | Cisplatin Ototoxicity and Its Prevention Lisa Cunningham, PhD, National Institute on Deafness and Other Communication Disorders (NIDCD) |
| 9:45–10:00 am | Break |
| 10:00–10:45 am | Aminoglycoside Ototoxicity and its Prevention Angela Garinis, PhD, National Center for Rehabilitative Auditory Research (NCRAR) |
| 10:45–11:15 am | Selected Poster Presentation (2- to 5-minute talks selected from attendee poster submissions) |
| 11:15 am–12:00 pm | Panel Discussion/Questions |
| 12:00–1:00 pm | Lunch Break |
| 1:00–1:15 pm | Welcome—Advanced Session Gayla Poling AuD, PhD, ARC 2023 Program Committee Co-Chair |
| 1:15–2:00 pm | Protection of the Inner Ear from Noise and Toxins: Clinical Trials Update Colleen Le Prell, PhD, University of Texas at Dallas |
| 2:00–2:45 pm | Gene Therapies for Childhood Hearing Loss Karen Avraham, PhD, Tel Aviv University |
| 2:45–3:00 pm | Break |
| 3:00–3:45 pm | Beyond the Audiogram: Lessons from Clinical Trials Victoria Sanchez, AuD, PhD, University of South Florida |
| 3:45–4:30 pm | The Audiologist in the Next Generation of Inner-Ear Therapies: From Devices to Drugs Angela Shoup, PhD, Callier Center for Communication Disorders/University of Texas-Dallas |
| 4:30–5:15 pm | Panel Discussion/Questions |
| 5:15–5:30 pm | Closing Remarks Colleen Le Prell, PhD, ARC 2023 Program Committee Chair |
Chair: Colleen Le Prell, PhDCo-Chair: Gayla Poling AuD, PhD
The fields of audiology and hearing science are vastly advancing. Nearly a quarter of Americans older than 12 years of age are estimated to have some degree of hearing loss. As most older adults will experience hearing loss, inner-ear regeneration and cell therapies would significantly expand remediation options beyond amplification devices alone. Research indicates that inner-ear regenerative therapies are promising and could lead to significant changes in audiological management. Multiple therapeutics are currently under evaluation in animal models and human clinical trials, with the potential for new medicines thus on the horizon.
This virtual conference aims to describe the current state of these therapies and provide future expectations for clinicians providing hearing-related services.
Agenda
| 8:00–8:15 am | Welcome–Background and Introductory Session Bopanna Ballachanda, PhD, Academy President Colleen Le Prell, PhD, ARC 2023 Program Chair |
| 8:15–9:00 am | Developing and Testing Therapies for the Inner Ear Lakeisha Henry, MD, US Air Force (RET) |
| 9:00–9:45 am | Cisplatin Ototoxicity and Its Prevention Lisa Cunningham, PhD, National Institute on Deafness and Other Communication Disorders (NIDCD) |
| 9:45–10:00 am | Break |
| 10:00–10:45 am | Aminoglycoside Ototoxicity and its Prevention Angela Garinis, PhD, National Center for Rehabilitative Auditory Research (NCRAR) |
| 10:45–11:15 am | Selected Poster Presentation (2- to 5-minute talks selected from attendee poster submissions) |
| 11:15 am–12:00 pm | Panel Discussion/Questions |
| 12:00–1:00 pm | Lunch Break |
| 1:00–1:15 pm | Welcome—Advanced Session Gayla Poling AuD, PhD, ARC 2023 Program Committee Co-Chair |
| 1:15–2:00 pm | Protection of the Inner Ear from Noise and Toxins: Clinical Trials Update Colleen Le Prell, PhD, University of Texas at Dallas |
| 2:00–2:45 pm | Gene Therapies for Childhood Hearing Loss Karen Avraham, PhD, Tel Aviv University |
| 2:45–3:00 pm | Break |
| 3:00–3:45 pm | Beyond the Audiogram: Lessons from Clinical Trials Victoria Sanchez, AuD, PhD, University of South Florida |
| 3:45–4:30 pm | The Audiologist in the Next Generation of Inner-Ear Therapies: From Devices to Drugs Angela Shoup, PhD, Callier Center for Communication Disorders/University of Texas-Dallas |
| 4:30–5:15 pm | Panel Discussion/Questions |
| 5:15–5:30 pm | Closing Remarks Colleen Le Prell, PhD, ARC 2023 Program Committee Chair |
More Events
AAA 2023 + HearTECH Expo
Seattle is a city home to innovation and has been at the forefront of visionary adaptations from music…
Read More
